Literature DB >> 2399261

Abnormal growth and clonal proliferation of fibroblasts derived from kidneys with interstitial fibrosis.

H P Rodemann1, G A Müller.   

Abstract

Renal fibroblasts from normal kidneys (NKF cells) and from kidneys with interstitial fibrosis (FKIF cells) were established from biopsy material. In primary and passage 1 cell cultures, the amount of fibroblasts was increased by a factor of 5-10 in cultures derived from kidneys with interstitial fibrosis as compared with cultures of normal origin. As tested by clonal growth and growth kinetic experiments, FKIF cells showed significant alterations in the proliferation capacity and generation time resulting in a hyperproliferative growth in primary and secondary fibroblast cultures in vitro. Two-dimensional gel electrophoresis experiments of [35S]methionine-labeled intracellular polypeptides revealed that FKIF cells express two proteins, p53/6.1 and p48/7.5, that are not present in normal kidney and skin fibroblasts. In addition, as analyzed by two-dimensional gel electrophoresis of medium supernatants of FKIF cells, two secreted proteins specific for FKIF cells could be demonstrated. Cross-feeding experiments using conditioned medium of FKIF cells on cultures of normal human skin fibroblasts (NSF cells) revealed that FKIF cells may secrete proteins into the medium or may modify preexisting serum factors that can induce hyperproliferation in normal dermal fibroblasts. As tested by serial subcultivation and clonal analysis, FKIF cells exert significant changes in the differentiation pattern of potentially mitotic fibroblasts populations.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2399261     DOI: 10.3181/00379727-195-43118

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


  21 in total

1.  The potential of a niacinamide dominated cosmeceutical formulation on fibroblast activity and wound healing in vitro.

Authors:  Quenton Wessels; Etheresia Pretorius; Celeste M Smith; Hugo Nel
Journal:  Int Wound J       Date:  2012-08-14       Impact factor: 3.315

Review 2.  Reshaping the interstitium by platelet-derived growth factor. Implications for progressive renal disease.

Authors:  K A Nath
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

Review 3.  Extracellular matrix as a driver of progressive fibrosis.

Authors:  Jeremy Herrera; Craig A Henke; Peter B Bitterman
Journal:  J Clin Invest       Date:  2018-01-02       Impact factor: 14.808

Review 4.  Heterogeneity of myofibroblast phenotypic features: an example of fibroblastic cell plasticity.

Authors:  A Schmitt-Gräff; A Desmoulière; G Gabbiani
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

Review 5.  Fibroblasts and myofibroblasts in renal fibrosis.

Authors:  Soma Meran; Robert Steadman
Journal:  Int J Exp Pathol       Date:  2011-02-28       Impact factor: 1.925

Review 6.  Epigenetics within the matrix: a neo-regulator of fibrotic disease.

Authors:  Claire M Robinson; Chris J Watson; John A Baugh
Journal:  Epigenetics       Date:  2012-08-16       Impact factor: 4.528

7.  [Pathogenesis of interstitial kidney fibrosis. Studies in the rat model of unilateral ureteral obstruction].

Authors:  M Sommer; R Fünfstück
Journal:  Med Klin (Munich)       Date:  1997-10-15

8.  tPA is a potent mitogen for renal interstitial fibroblasts: role of beta1 integrin/focal adhesion kinase signaling.

Authors:  Sha Hao; Hongmei Shen; Yayi Hou; Wendy M Mars; Youhua Liu
Journal:  Am J Pathol       Date:  2010-07-16       Impact factor: 4.307

Review 9.  The progression of renal diseases: on the pathogenesis of renal interstitial fibrosis.

Authors:  G A Müller; J Markovic-Lipkovski; H P Rodemann
Journal:  Klin Wochenschr       Date:  1991-09-03

10.  Mesenchymal cells isolated after acute lung injury manifest an enhanced proliferative phenotype.

Authors:  B Chen; V Polunovsky; J White; B Blazar; R Nakhleh; J Jessurun; M Peterson; P Bitterman
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.